Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About David Elkins

David Elkins is recorded as CFO at Bristol Myers Squibb Co (BMY) and Board Member at Tapestry, Inc. (TPR). Tapestry, Inc. reported in an 8-K filed February 29, 2024 that David Elkins was appointed director, effective February 29, 2024. The proxy statement of Bristol Myers Squibb Co reports total compensation of $9,177,590 for David Elkins in fiscal 2025, including a base salary of $1,140,442. Disclosed compensation is on record for 4 fiscal years. David Elkins has spoken on 26 earnings calls across 1 company, most recently for Bristol Myers Squibb Co on July 30, 2026.

“the Board of Directors (the "Board") of Tapestry, Inc. ("Tapestry" or the "Company") increased the size of the Board from nine to eleven members and elected each of Kevin Hourican and David Elkins as a director of the Company, effective as of February 29, 2024.”
Tapestry, Inc. Form 8-K, filed February 29, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Bristol Myers Squibb Co

Other people whose current roles at this company are on record from its filings.

Leadership on record at Tapestry, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Bristol Myers Squibb Co (BMY) $1,140,442 $9,177,590
2024 Bristol Myers Squibb Co (BMY) $1,115,000 $8,707,571
2023 Bristol Myers Squibb Co (BMY) $1,106,176 $7,166,300
2022 Bristol Myers Squibb Co (BMY) $1,073,859 $7,647,290

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Show 15 earlier activities